These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38089084)

  • 1. Evaluation of quality of clinical management of neuroendocrine tumors.
    Bloemen H; Kneepkens K; Deraedt K; Ivanova A; Sergeant G; Mebis J; Van der Speeten K
    Cancer Innov; 2022 Dec; 1(4):305-315. PubMed ID: 38089084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Management of Appendiceal Neuroendocrine Tumors in Pediatric Population: A Bicentric Experience with 6285 Appendectomies.
    Pogorelić Z; Ercegović V; Bašković M; Jukić M; Karaman I; Mrklić I
    Children (Basel); 2023 Dec; 10(12):. PubMed ID: 38136101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
    Ambrosini V; Kunikowska J; Baudin E; Bodei L; Bouvier C; Capdevila J; Cremonesi M; de Herder WW; Dromain C; Falconi M; Fani M; Fanti S; Hicks RJ; Kabasakal L; Kaltsas G; Lewington V; Minozzi S; Cinquini M; Öberg K; Oyen WJG; O'Toole D; Pavel M; Ruszniewski P; Scarpa A; Strosberg J; Sundin A; Taïeb D; Virgolini I; Wild D; Herrmann K; Yao J
    Eur J Cancer; 2021 Mar; 146():56-73. PubMed ID: 33588146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinicopathological Significance of Tumor Cell Subtyping in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors.
    Mete O; Dodington DW; Shen DL; Asa SL
    Endocr Pathol; 2024 Jun; 35(2):107-112. PubMed ID: 38833137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.
    Hörsch D; Schmid KW; Anlauf M; Darwiche K; Denecke T; Baum RP; Spitzweg C; Grohé C; Presselt N; Stremmel C; Heigener DF; Serke M; Kegel T; Pavel M; Waller CF; Deppermann KM; Arnold R; Huber RM; Weber MM; Hoffmann H
    Oncol Res Treat; 2014; 37(5):266-76. PubMed ID: 24853787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
    Mujica-Mota R; Varley-Campbell J; Tikhonova I; Cooper C; Griffin E; Haasova M; Peters J; Lucherini S; Talens-Bou J; Long L; Sherriff D; Napier M; Ramage J; Hoyle M
    Health Technol Assess; 2018 Sep; 22(49):1-326. PubMed ID: 30209002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.
    Guo LJ; Wang CH; Tang CW
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):284-8. PubMed ID: 27170574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of extra-appendiceal colorectal neuroendocrine tumors.
    Maryański J; Cyran-Chlebicka A; Szczepankiewicz B; Cebulski W; Słodkowski M; Wroński M
    Pol Przegl Chir; 2018 May; 90(3):7-12. PubMed ID: 30015320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
    Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
    JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of ODF1 in Gastrointestinal Tract Neuroendocrine Neoplasms: a Novel Potential Immunohistochemical Biomarker for Well-differentiated Neuroendocrine Tumors.
    Li B; Li X; Mao R; Liu M; Fu L; Shi L; Zhao S; Fu M
    Endocr Pathol; 2021 Jun; 32(2):301-308. PubMed ID: 32869188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroendocrine tumors: analysis of 252 cases].
    Chi YH; Jiang WC; Du F; Sun YK; Song Y; Yang L; Zhou AP; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):67-70. PubMed ID: 23648305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus.
    Singh S; Asa SL; Dey C; Kennecke H; Laidley D; Law C; Asmis T; Chan D; Ezzat S; Goodwin R; Mete O; Pasieka J; Rivera J; Wong R; Segelov E; Rayson D
    Cancer Treat Rev; 2016 Jun; 47():32-45. PubMed ID: 27236421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
    Nesti C; Bräutigam K; Benavent M; Bernal L; Boharoon H; Botling J; Bouroumeau A; Brcic I; Brunner M; Cadiot G; Camara M; Christ E; Clerici T; Clift AK; Clouston H; Cobianchi L; Ćwikła JB; Daskalakis K; Frilling A; Garcia-Carbonero R; Grozinsky-Glasberg S; Hernando J; Hervieu V; Hofland J; Holmager P; Inzani F; Jann H; Jimenez-Fonseca P; Kaçmaz E; Kaemmerer D; Kaltsas G; Klimacek B; Knigge U; Kolasińska-Ćwikła A; Kolb W; Kos-Kudła B; Kunze CA; Landolfi S; La Rosa S; López CL; Lorenz K; Matter M; Mazal P; Mestre-Alagarda C; Del Burgo PM; van Dijkum EJMN; Oleinikov K; Orci LA; Panzuto F; Pavel M; Perrier M; Reims HM; Rindi G; Rinke A; Rinzivillo M; Sagaert X; Satiroglu I; Selberherr A; Siebenhüner AR; Tesselaar MET; Thalhammer MJ; Thiis-Evensen E; Toumpanakis C; Vandamme T; van den Berg JG; Vanoli A; van Velthuysen MF; Verslype C; Vorburger SA; Lugli A; Ramage J; Zwahlen M; Perren A; Kaderli RM
    Lancet Oncol; 2023 Feb; 24(2):187-194. PubMed ID: 36640790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors.
    Ploeckinger U; Kloeppel G; Wiedenmann B; Lohmann R;
    Neuroendocrinology; 2009; 90(4):349-63. PubMed ID: 19776553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Neuroendocrine Tumors in an Iranian Population.
    MalekZadeh M; Alahyari S; Sandoughdaran S; Zham H
    Arch Iran Med; 2017 Oct; 20(10):652-654. PubMed ID: 29137468
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.